Table of Contents
SAN DIEGO — Innovus Pharmaceuticals Inc. has begun rolling out FlutiCare OTC allergy nasal spray to U.S. pharmacies.
Innovus said Tuesday that FlutiCare OTC (fluticasone propionate) is initially being launched in more than 10,000 independent pharmacies and through distributors McKesson and AmerisourceBergen, as well as direct, via its Beyond Human print media platform and online channels, including its website, Amazon.com and Walmart.com.
Plans call for a second-phase launch to bring FlutiCare OTC to large retail stores, according to Innovus.
FlutiCare OTC has the same strength and delivery method as GSK Consumer Healthcare’s Flonase and Bayer Consumer Health’s ClariSpray allergy nasal sprays, Innovus reported. The company said that FlutiCare OTC will be the most affordable fluticasone propionate nasal spray on the market, and it’s the only one providing the product via a monthly auto-ship plan.
A nasal corticosteroid, FlutiCare OTC provides 50 mcg of fluticasone propionate per spray and comes in a 30-day treatment (120 sprays). The product is indicated to provide 24-hour relief of seasonal and perennial nasal allergy symptoms — including congestion, runny nose, sneezing and itchy nose — from indoor and outdoor triggers, such as pollen, dust, animal dander and other allergens.
“We are very excited to launch FlutiCare OTC and provide all patients with allergy relief,” commented Bassam Damaj, president and chief executive officer of Innovus Pharmaceuticals. “FlutiCare traces its roots as the most prescribed Rx 24-hour nasal allergy spray API and form in the U.S. over the past seven years by a factor of over 10 to 1.”
FlutiCare OTC marks Innovus’ second allergy product on the market, joining AllerVarx, a dietary supplement formulated to provide relief during the allergy season. The company added that, pending Food and Drug Administration guidance, it plans a fluticasone kit for nasal allergy symptoms that would include FlutiCare and NasaVa, its upcoming saline nasal spray .
